A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

Project: Research project

Description

A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06651600 AND PF-06700841 IN SUBJECTS WITH MODERATE TO SEVERE ALOPECIA AREATA
StatusActive
Effective start/end date6/21/171/30/22

Funding

  • PFIZER, INC.

Fingerprint

Alopecia Areata
Multicenter Studies
Placebos
Safety